PharmaJet Partner Gennova Biopharmaceuticals Seeks Emergency Use Authorization in India for the First Needle-Free mRNA Vaccine Omicron Booster
Interim report of the safety and immunogenicity endpoints from the Phase II/III study has been submitted to the Drug Controller...



















